Plinabulin enhances anti-tumor immunity by promoting M1-like macrophages, activating JNK pathway, and directly killing tumor cells in a Fas/Fas-L dependent manner; effective even in T cell-deficient environments. This evidence concerns the gene FASLG and neoplasm.